Giving full measure to countermeasures :: addressing problems in the DoD program to develop medical countermeasures against biological warfare agents /
"In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be used in bioterrorist attacks against civilian populations. According to a new congressionally mandated report from the Institute of M...
Gespeichert in:
| Körperschaft: | |
|---|---|
| Weitere Verfasser: | , , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
National Academies Press,
©2004.
|
| Schriftenreihe: | Online access: NCBI NCBI Bookshelf.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | "In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be used in bioterrorist attacks against civilian populations. According to a new congressionally mandated report from the Institute of Medicine and National Research Council of the National Academies, to successfully develop these drugs, vaccines, and other medical interventions against biowarfare agents, Congress should authorize the creation of a new agency within the Office of the Secretary of the U.S. Department of Defense. The committee recommended that Congress should improve liability protections for those who develop and manufacture these products, to stimulate willingness to invest in new research and development for biowarfare protection. Giving Full Measure to Countermeasures also identifies other challenges such as the need for appropriate animal models and laboratories equipped with high-level biosafety protections that will require attention if DoD efforts to develop new medical countermeasures are to be successful."--Publisher's description |
| Beschreibung: | 1 online resource (xix, 139 pages) : illustrations |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 0309530334 9780309530330 |
Internformat
MARC
| LEADER | 00000cam a22000004a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocm55636256 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 040611s2004 dcua ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d YDXCP |d OCLCG |d OCLCQ |d COF |d OCLCQ |d TUU |d OCLCQ |d LML |d CU3 |d OCLCQ |d GAO |d SBH |d INU |d DKDLA |d QT5 |d ADU |d E7B |d IDEBK |d OCLCO |d OCLCQ |d NLGGC |d OCLCO |d OCLCQ |d OCLCO |d QMC |d EBLCP |d OCLCQ |d AZK |d OCLCO |d AGLDB |d MOR |d CCO |d PIFBR |d OCLCO |d ZCU |d OCLCO |d OCLCQ |d MERUC |d OCLCO |d OCLCQ |d SAV |d OCLCO |d OCLCQ |d WY@ |d OCLCO |d OCLCA |d U3W |d ROC |d OCLCO |d VT2 |d OCLCO |d BUF |d OCLCO |d LUE |d OCLCO |d OCLCF |d OCLCO |d RCC |d OCLCO |d STF |d OCLCO |d WRM |d GILDS |d OCLCO |d VNS |d OCLCO |d MNI |d OCLCO |d WCO |d OCLCO |d OCLCQ |d VTS |d COCUF |d NRAMU |d XOS |d XQH |d EZ9 |d ICG |d OCLCO |d OCLCQ |d OCLCO |d INT |d TOF |d OCLCO |d AU@ |d OCLCQ |d OCLCO |d WYU |d LVT |d S9I |d TKN |d OCLCO |d G3B |d U3G |d DKC |d OCLCQ |d K6U |d CHBRC |d OCLCO |d UKAHL |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 54089574 |a 70773128 |a 479531326 |a 531339927 |a 614584187 |a 630212233 |a 647359840 |a 666922367 |a 722249076 |a 888714873 |a 923262669 |a 961646650 |a 961657437 |a 962678874 |a 962683988 |a 991957116 |a 1020542038 |a 1053111131 |a 1135406081 |a 1229456861 | ||
| 020 | |a 0309530334 |q (electronic bk.) | ||
| 020 | |a 9780309530330 |q (electronic bk.) | ||
| 020 | |z 0309091535 |q (pbk.) | ||
| 020 | |z 9780309091534 |q (pbk.) | ||
| 035 | |a (OCoLC)55636256 |z (OCoLC)54089574 |z (OCoLC)70773128 |z (OCoLC)479531326 |z (OCoLC)531339927 |z (OCoLC)614584187 |z (OCoLC)630212233 |z (OCoLC)647359840 |z (OCoLC)666922367 |z (OCoLC)722249076 |z (OCoLC)888714873 |z (OCoLC)923262669 |z (OCoLC)961646650 |z (OCoLC)961657437 |z (OCoLC)962678874 |z (OCoLC)962683988 |z (OCoLC)991957116 |z (OCoLC)1020542038 |z (OCoLC)1053111131 |z (OCoLC)1135406081 |z (OCoLC)1229456861 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a UG447.8 |b .G58 2004eb | |
| 060 | 4 | |a 2004 F-613 | |
| 060 | 4 | |a UG 447.8 |b G539 2004 | |
| 072 | 7 | |a HIS |x 027010 |2 bisacsh | |
| 082 | 7 | |a 358/.38 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Giving full measure to countermeasures : |b addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / |c Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents, Medical Follow-up Agency and Board on Life Sciences ; Lois M. Joellenbeck, Jane S. Durch, and Leslie Z. Benet, editors. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2004. | ||
| 300 | |a 1 online resource (xix, 139 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 504 | |a Includes bibliographical references. | ||
| 588 | 0 | |a Print version record. | |
| 520 | |a "In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be used in bioterrorist attacks against civilian populations. According to a new congressionally mandated report from the Institute of Medicine and National Research Council of the National Academies, to successfully develop these drugs, vaccines, and other medical interventions against biowarfare agents, Congress should authorize the creation of a new agency within the Office of the Secretary of the U.S. Department of Defense. The committee recommended that Congress should improve liability protections for those who develop and manufacture these products, to stimulate willingness to invest in new research and development for biowarfare protection. Giving Full Measure to Countermeasures also identifies other challenges such as the need for appropriate animal models and laboratories equipped with high-level biosafety protections that will require attention if DoD efforts to develop new medical countermeasures are to be successful."--Publisher's description | ||
| 505 | 0 | |a FrontMatter -- Reviewers -- Preface -- Contents -- Figures, Tables, and Boxes -- Abbreviations and Acronyms -- Executive Summary -- 1 Ending Half-Measures for Countermeasures: The Challenge and Major Recommendations -- 2 Organizing Research and Development for Medical Countermeasures to Accomplish Essential Functions -- 3 Challenges in the Research and Development of Medical Countermeasures Against Biological Warfare Agents -- APPENDIXES -- APPENDIX A Background: The Current DoD Medical Biowarfare Countermeasures Program | |
| 505 | 8 | |a APPENDIX B Agendas for Information-Gathering MeetingsAPPENDIX C Acknowledgments -- APPENDIX D Biographical Sketches | |
| 610 | 1 | 2 | |a United States |b Department of Defense |
| 650 | 0 | |a Biological warfare |x Health aspects |z United States. | |
| 650 | 0 | |a Biological warfare |z United States |x Safety measures. | |
| 650 | 0 | |a Biological weapons |x Health aspects |z United States. | |
| 650 | 0 | |a Biological weapons |z United States |x Safety measures. | |
| 650 | 0 | |a Medicine, Preventive |z United States. | |
| 650 | 0 | |a Antitoxins |z United States. | |
| 650 | 0 | |a Vaccines |z United States. | |
| 650 | 6 | |a Guerre biologique |z États-Unis |x Sécurité |x Mesures. | |
| 650 | 6 | |a Armes biologiques |x Sécurité |x Mesures |z États-Unis. | |
| 650 | 6 | |a Médecine préventive |z États-Unis. | |
| 650 | 6 | |a Antitoxines |z États-Unis. | |
| 650 | 6 | |a Vaccins |z États-Unis. | |
| 650 | 7 | |a HISTORY |x Military |x Biological & Chemical Warfare. |2 bisacsh | |
| 650 | 7 | |a Antitoxins |2 fast | |
| 650 | 7 | |a Biological warfare |x Health aspects |2 fast | |
| 650 | 7 | |a Biological warfare |x Safety measures |2 fast | |
| 650 | 7 | |a Biological weapons |x Safety measures |2 fast | |
| 650 | 7 | |a Medicine, Preventive |2 fast | |
| 650 | 7 | |a Vaccines |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 700 | 1 | |a Joellenbeck, Lois M. |q (Lois Mary), |d 1963- |1 https://id.oclc.org/worldcat/entity/E39PCjyG9Q7Fq6v8F8hkd4f3pK |0 http://id.loc.gov/authorities/names/n00005608 | |
| 700 | 1 | |a Durch, Jane. |0 http://id.loc.gov/authorities/names/n81044480 | |
| 700 | 1 | |a Benet, Leslie Z. |0 http://id.loc.gov/authorities/names/n83004972 | |
| 710 | 2 | |a Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents. |0 http://id.loc.gov/authorities/names/n2004119979 | |
| 776 | 0 | 8 | |i Print version: |t Giving full measure to countermeasures. |d Washington, D.C. : National Academies Press, ©2004 |z 0309091535 |w (DLC) 2004005890 |w (OCoLC)54768469 |
| 830 | 0 | |a Online access: NCBI NCBI Bookshelf. | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=109217 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36615629 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL3376295 | ||
| 938 | |a ebrary |b EBRY |n ebr10055384 | ||
| 938 | |a EBSCOhost |b EBSC |n 109217 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 17636 | ||
| 938 | |a YBP Library Services |b YANK |n 2293394 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocm55636256 |
|---|---|
| _version_ | 1816881615722250240 |
| adam_text | |
| any_adam_object | |
| author2 | Joellenbeck, Lois M. (Lois Mary), 1963- Durch, Jane Benet, Leslie Z. |
| author2_role | |
| author2_variant | l m j lm lmj j d jd l z b lz lzb |
| author_GND | http://id.loc.gov/authorities/names/n00005608 http://id.loc.gov/authorities/names/n81044480 http://id.loc.gov/authorities/names/n83004972 |
| author_corporate | Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents |
| author_corporate_role | |
| author_facet | Joellenbeck, Lois M. (Lois Mary), 1963- Durch, Jane Benet, Leslie Z. Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents |
| author_sort | Joellenbeck, Lois M. 1963- |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | U - Military Science |
| callnumber-label | UG447 |
| callnumber-raw | UG447.8 .G58 2004eb |
| callnumber-search | UG447.8 .G58 2004eb |
| callnumber-sort | UG 3447.8 G58 42004EB |
| callnumber-subject | UG - Military Engineering and Air Forces |
| collection | ZDB-4-EBA |
| contents | FrontMatter -- Reviewers -- Preface -- Contents -- Figures, Tables, and Boxes -- Abbreviations and Acronyms -- Executive Summary -- 1 Ending Half-Measures for Countermeasures: The Challenge and Major Recommendations -- 2 Organizing Research and Development for Medical Countermeasures to Accomplish Essential Functions -- 3 Challenges in the Research and Development of Medical Countermeasures Against Biological Warfare Agents -- APPENDIXES -- APPENDIX A Background: The Current DoD Medical Biowarfare Countermeasures Program APPENDIX B Agendas for Information-Gathering MeetingsAPPENDIX C Acknowledgments -- APPENDIX D Biographical Sketches |
| ctrlnum | (OCoLC)55636256 |
| dewey-full | 358/.38 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 358 - Air & other specialized forces |
| dewey-raw | 358/.38 |
| dewey-search | 358/.38 |
| dewey-sort | 3358 238 |
| dewey-tens | 350 - Public administration and military science |
| discipline | Militärwissenschaft |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06913cam a22008294a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm55636256 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu|||unuuu</controlfield><controlfield tag="008">040611s2004 dcua ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">COF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TUU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">LML</subfield><subfield code="d">CU3</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">GAO</subfield><subfield code="d">SBH</subfield><subfield code="d">INU</subfield><subfield code="d">DKDLA</subfield><subfield code="d">QT5</subfield><subfield code="d">ADU</subfield><subfield code="d">E7B</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">QMC</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">CCO</subfield><subfield code="d">PIFBR</subfield><subfield code="d">OCLCO</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">SAV</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WY@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">ROC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCO</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">LUE</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">RCC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WRM</subfield><subfield code="d">GILDS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MNI</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WCO</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">COCUF</subfield><subfield code="d">NRAMU</subfield><subfield code="d">XOS</subfield><subfield code="d">XQH</subfield><subfield code="d">EZ9</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">INT</subfield><subfield code="d">TOF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WYU</subfield><subfield code="d">LVT</subfield><subfield code="d">S9I</subfield><subfield code="d">TKN</subfield><subfield code="d">OCLCO</subfield><subfield code="d">G3B</subfield><subfield code="d">U3G</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">CHBRC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">54089574</subfield><subfield code="a">70773128</subfield><subfield code="a">479531326</subfield><subfield code="a">531339927</subfield><subfield code="a">614584187</subfield><subfield code="a">630212233</subfield><subfield code="a">647359840</subfield><subfield code="a">666922367</subfield><subfield code="a">722249076</subfield><subfield code="a">888714873</subfield><subfield code="a">923262669</subfield><subfield code="a">961646650</subfield><subfield code="a">961657437</subfield><subfield code="a">962678874</subfield><subfield code="a">962683988</subfield><subfield code="a">991957116</subfield><subfield code="a">1020542038</subfield><subfield code="a">1053111131</subfield><subfield code="a">1135406081</subfield><subfield code="a">1229456861</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309530334</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309530330</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309091535</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309091534</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)55636256</subfield><subfield code="z">(OCoLC)54089574</subfield><subfield code="z">(OCoLC)70773128</subfield><subfield code="z">(OCoLC)479531326</subfield><subfield code="z">(OCoLC)531339927</subfield><subfield code="z">(OCoLC)614584187</subfield><subfield code="z">(OCoLC)630212233</subfield><subfield code="z">(OCoLC)647359840</subfield><subfield code="z">(OCoLC)666922367</subfield><subfield code="z">(OCoLC)722249076</subfield><subfield code="z">(OCoLC)888714873</subfield><subfield code="z">(OCoLC)923262669</subfield><subfield code="z">(OCoLC)961646650</subfield><subfield code="z">(OCoLC)961657437</subfield><subfield code="z">(OCoLC)962678874</subfield><subfield code="z">(OCoLC)962683988</subfield><subfield code="z">(OCoLC)991957116</subfield><subfield code="z">(OCoLC)1020542038</subfield><subfield code="z">(OCoLC)1053111131</subfield><subfield code="z">(OCoLC)1135406081</subfield><subfield code="z">(OCoLC)1229456861</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">UG447.8</subfield><subfield code="b">.G58 2004eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2004 F-613</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">UG 447.8</subfield><subfield code="b">G539 2004</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HIS</subfield><subfield code="x">027010</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">358/.38</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Giving full measure to countermeasures :</subfield><subfield code="b">addressing problems in the DoD program to develop medical countermeasures against biological warfare agents /</subfield><subfield code="c">Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents, Medical Follow-up Agency and Board on Life Sciences ; Lois M. Joellenbeck, Jane S. Durch, and Leslie Z. Benet, editors.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">©2004.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xix, 139 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be used in bioterrorist attacks against civilian populations. According to a new congressionally mandated report from the Institute of Medicine and National Research Council of the National Academies, to successfully develop these drugs, vaccines, and other medical interventions against biowarfare agents, Congress should authorize the creation of a new agency within the Office of the Secretary of the U.S. Department of Defense. The committee recommended that Congress should improve liability protections for those who develop and manufacture these products, to stimulate willingness to invest in new research and development for biowarfare protection. Giving Full Measure to Countermeasures also identifies other challenges such as the need for appropriate animal models and laboratories equipped with high-level biosafety protections that will require attention if DoD efforts to develop new medical countermeasures are to be successful."--Publisher's description</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">FrontMatter -- Reviewers -- Preface -- Contents -- Figures, Tables, and Boxes -- Abbreviations and Acronyms -- Executive Summary -- 1 Ending Half-Measures for Countermeasures: The Challenge and Major Recommendations -- 2 Organizing Research and Development for Medical Countermeasures to Accomplish Essential Functions -- 3 Challenges in the Research and Development of Medical Countermeasures Against Biological Warfare Agents -- APPENDIXES -- APPENDIX A Background: The Current DoD Medical Biowarfare Countermeasures Program</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">APPENDIX B Agendas for Information-Gathering MeetingsAPPENDIX C Acknowledgments -- APPENDIX D Biographical Sketches</subfield></datafield><datafield tag="610" ind1="1" ind2="2"><subfield code="a">United States</subfield><subfield code="b">Department of Defense</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biological warfare</subfield><subfield code="x">Health aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biological warfare</subfield><subfield code="z">United States</subfield><subfield code="x">Safety measures.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biological weapons</subfield><subfield code="x">Health aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biological weapons</subfield><subfield code="z">United States</subfield><subfield code="x">Safety measures.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine, Preventive</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Antitoxins</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccines</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Guerre biologique</subfield><subfield code="z">États-Unis</subfield><subfield code="x">Sécurité</subfield><subfield code="x">Mesures.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Armes biologiques</subfield><subfield code="x">Sécurité</subfield><subfield code="x">Mesures</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine préventive</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Antitoxines</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccins</subfield><subfield code="z">États-Unis.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HISTORY</subfield><subfield code="x">Military</subfield><subfield code="x">Biological & Chemical Warfare.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antitoxins</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biological warfare</subfield><subfield code="x">Health aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biological warfare</subfield><subfield code="x">Safety measures</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biological weapons</subfield><subfield code="x">Safety measures</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine, Preventive</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccines</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Joellenbeck, Lois M.</subfield><subfield code="q">(Lois Mary),</subfield><subfield code="d">1963-</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCjyG9Q7Fq6v8F8hkd4f3pK</subfield><subfield code="0">http://id.loc.gov/authorities/names/n00005608</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Durch, Jane.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n81044480</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Benet, Leslie Z.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n83004972</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2004119979</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Giving full measure to countermeasures.</subfield><subfield code="d">Washington, D.C. : National Academies Press, ©2004</subfield><subfield code="z">0309091535</subfield><subfield code="w">(DLC) 2004005890</subfield><subfield code="w">(OCoLC)54768469</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Online access: NCBI NCBI Bookshelf.</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=109217</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36615629</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3376295</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10055384</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">109217</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">17636</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2293394</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| geographic | United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocm55636256 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:15:32Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n2004119979 |
| isbn | 0309530334 9780309530330 |
| language | English |
| oclc_num | 55636256 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xix, 139 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | National Academies Press, |
| record_format | marc |
| series | Online access: NCBI NCBI Bookshelf. |
| spelling | Giving full measure to countermeasures : addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents, Medical Follow-up Agency and Board on Life Sciences ; Lois M. Joellenbeck, Jane S. Durch, and Leslie Z. Benet, editors. Washington, D.C. : National Academies Press, ©2004. 1 online resource (xix, 139 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier data file Includes bibliographical references. Print version record. "In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be used in bioterrorist attacks against civilian populations. According to a new congressionally mandated report from the Institute of Medicine and National Research Council of the National Academies, to successfully develop these drugs, vaccines, and other medical interventions against biowarfare agents, Congress should authorize the creation of a new agency within the Office of the Secretary of the U.S. Department of Defense. The committee recommended that Congress should improve liability protections for those who develop and manufacture these products, to stimulate willingness to invest in new research and development for biowarfare protection. Giving Full Measure to Countermeasures also identifies other challenges such as the need for appropriate animal models and laboratories equipped with high-level biosafety protections that will require attention if DoD efforts to develop new medical countermeasures are to be successful."--Publisher's description FrontMatter -- Reviewers -- Preface -- Contents -- Figures, Tables, and Boxes -- Abbreviations and Acronyms -- Executive Summary -- 1 Ending Half-Measures for Countermeasures: The Challenge and Major Recommendations -- 2 Organizing Research and Development for Medical Countermeasures to Accomplish Essential Functions -- 3 Challenges in the Research and Development of Medical Countermeasures Against Biological Warfare Agents -- APPENDIXES -- APPENDIX A Background: The Current DoD Medical Biowarfare Countermeasures Program APPENDIX B Agendas for Information-Gathering MeetingsAPPENDIX C Acknowledgments -- APPENDIX D Biographical Sketches United States Department of Defense Biological warfare Health aspects United States. Biological warfare United States Safety measures. Biological weapons Health aspects United States. Biological weapons United States Safety measures. Medicine, Preventive United States. Antitoxins United States. Vaccines United States. Guerre biologique États-Unis Sécurité Mesures. Armes biologiques Sécurité Mesures États-Unis. Médecine préventive États-Unis. Antitoxines États-Unis. Vaccins États-Unis. HISTORY Military Biological & Chemical Warfare. bisacsh Antitoxins fast Biological warfare Health aspects fast Biological warfare Safety measures fast Biological weapons Safety measures fast Medicine, Preventive fast Vaccines fast United States fast https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Joellenbeck, Lois M. (Lois Mary), 1963- https://id.oclc.org/worldcat/entity/E39PCjyG9Q7Fq6v8F8hkd4f3pK http://id.loc.gov/authorities/names/n00005608 Durch, Jane. http://id.loc.gov/authorities/names/n81044480 Benet, Leslie Z. http://id.loc.gov/authorities/names/n83004972 Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents. http://id.loc.gov/authorities/names/n2004119979 Print version: Giving full measure to countermeasures. Washington, D.C. : National Academies Press, ©2004 0309091535 (DLC) 2004005890 (OCoLC)54768469 Online access: NCBI NCBI Bookshelf. FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=109217 Volltext |
| spellingShingle | Giving full measure to countermeasures : addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / Online access: NCBI NCBI Bookshelf. FrontMatter -- Reviewers -- Preface -- Contents -- Figures, Tables, and Boxes -- Abbreviations and Acronyms -- Executive Summary -- 1 Ending Half-Measures for Countermeasures: The Challenge and Major Recommendations -- 2 Organizing Research and Development for Medical Countermeasures to Accomplish Essential Functions -- 3 Challenges in the Research and Development of Medical Countermeasures Against Biological Warfare Agents -- APPENDIXES -- APPENDIX A Background: The Current DoD Medical Biowarfare Countermeasures Program APPENDIX B Agendas for Information-Gathering MeetingsAPPENDIX C Acknowledgments -- APPENDIX D Biographical Sketches United States Department of Defense Biological warfare Health aspects United States. Biological warfare United States Safety measures. Biological weapons Health aspects United States. Biological weapons United States Safety measures. Medicine, Preventive United States. Antitoxins United States. Vaccines United States. Guerre biologique États-Unis Sécurité Mesures. Armes biologiques Sécurité Mesures États-Unis. Médecine préventive États-Unis. Antitoxines États-Unis. Vaccins États-Unis. HISTORY Military Biological & Chemical Warfare. bisacsh Antitoxins fast Biological warfare Health aspects fast Biological warfare Safety measures fast Biological weapons Safety measures fast Medicine, Preventive fast Vaccines fast |
| title | Giving full measure to countermeasures : addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / |
| title_auth | Giving full measure to countermeasures : addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / |
| title_exact_search | Giving full measure to countermeasures : addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / |
| title_full | Giving full measure to countermeasures : addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents, Medical Follow-up Agency and Board on Life Sciences ; Lois M. Joellenbeck, Jane S. Durch, and Leslie Z. Benet, editors. |
| title_fullStr | Giving full measure to countermeasures : addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents, Medical Follow-up Agency and Board on Life Sciences ; Lois M. Joellenbeck, Jane S. Durch, and Leslie Z. Benet, editors. |
| title_full_unstemmed | Giving full measure to countermeasures : addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures against Biological Warfare Agents, Medical Follow-up Agency and Board on Life Sciences ; Lois M. Joellenbeck, Jane S. Durch, and Leslie Z. Benet, editors. |
| title_short | Giving full measure to countermeasures : |
| title_sort | giving full measure to countermeasures addressing problems in the dod program to develop medical countermeasures against biological warfare agents |
| title_sub | addressing problems in the DoD program to develop medical countermeasures against biological warfare agents / |
| topic | United States Department of Defense Biological warfare Health aspects United States. Biological warfare United States Safety measures. Biological weapons Health aspects United States. Biological weapons United States Safety measures. Medicine, Preventive United States. Antitoxins United States. Vaccines United States. Guerre biologique États-Unis Sécurité Mesures. Armes biologiques Sécurité Mesures États-Unis. Médecine préventive États-Unis. Antitoxines États-Unis. Vaccins États-Unis. HISTORY Military Biological & Chemical Warfare. bisacsh Antitoxins fast Biological warfare Health aspects fast Biological warfare Safety measures fast Biological weapons Safety measures fast Medicine, Preventive fast Vaccines fast |
| topic_facet | United States Department of Defense Biological warfare Health aspects United States. Biological warfare United States Safety measures. Biological weapons Health aspects United States. Biological weapons United States Safety measures. Medicine, Preventive United States. Antitoxins United States. Vaccines United States. Guerre biologique États-Unis Sécurité Mesures. Armes biologiques Sécurité Mesures États-Unis. Médecine préventive États-Unis. Antitoxines États-Unis. Vaccins États-Unis. HISTORY Military Biological & Chemical Warfare. Antitoxins Biological warfare Health aspects Biological warfare Safety measures Biological weapons Safety measures Medicine, Preventive Vaccines United States |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=109217 |
| work_keys_str_mv | AT joellenbeckloism givingfullmeasuretocountermeasuresaddressingproblemsinthedodprogramtodevelopmedicalcountermeasuresagainstbiologicalwarfareagents AT durchjane givingfullmeasuretocountermeasuresaddressingproblemsinthedodprogramtodevelopmedicalcountermeasuresagainstbiologicalwarfareagents AT benetlesliez givingfullmeasuretocountermeasuresaddressingproblemsinthedodprogramtodevelopmedicalcountermeasuresagainstbiologicalwarfareagents AT committeeonacceleratingtheresearchdevelopmentandacquisitionofmedicalcountermeasuresagainstbiologicalwarfareagents givingfullmeasuretocountermeasuresaddressingproblemsinthedodprogramtodevelopmedicalcountermeasuresagainstbiologicalwarfareagents |